The company plans to use the new funds to launch its Stim Assist and its Alife mobile app.
The company announced a deal with Indegene to launch Regulora, its recently FDA-approved prescription digital therapeutic for treating abdominal pain associated with IBS.
A Nature article outlines the digital health approaches of nine countries around the world.
Also: Telehealth startup Antidote Health and fertility tech company Alife Health both raise $22 million.
The app has correctly detected COVID-19 in 92% of infected participants of a clinical trial.
As part of the agreement, SoftBank will research market opportunities for the digital therapeutic, and it can negotiate an exclusive commercialization deal in Japan.
